Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘16
551
17 28 11 28.7%
552
17 57 40 93.5%
553
17 34 17 87.7%
LCTX icon
554
Lineage Cell Therapeutics
LCTX
$405M
17 27 10 48.4%
555
17 61 44 50.3%
556
17 379 362 221%
557
17 35 18 3.71%
558
17 58 41 66.4%
559
17 54 37 75.2%
560
17 32 15 23.2%
ANF icon
561
Abercrombie & Fitch
ANF
$4.71B
17 93 76 547%
562
17 49 32 247%
563
16 30 14 112%
564
16 41 25 982%
565
16 42 26 101%
566
16 78 62 54.8%
567
16 134 118 5.82%
568
16 31 15 150%
569
16 143 127 71.6%
570
16 44 28 94.7%
571
16 39 23 91.4%
572
16 111 95 52.5%
573
16 56 40 50.6%
574
16 23 7 37.1%
575
16 37 21 80.6%